I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Thirman, Michael J.
93
results:
Search for persons
X
Format
Online (93)
Mediatypes
Articles (Online) (49)
OpenAccess-fulltext (44)
Sorted by: Relevance
Sorted by: Year
?
1
Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine ..:
Pratz, Keith W.
;
Jonas, Brian A.
;
Pullarkat, Vinod
...
American Journal of Hematology. 99 (2024) 4 - p. 615-624 , 2024
Link:
https://doi.org/10.1002/..
?
2
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-m..:
Issa, Ghayas C.
;
Aldoss, Ibrahim
;
DiPersio, John
...
Nature. 615 (2023) 7954 - p. 920-924 , 2023
Link:
https://doi.org/10.1038/..
?
3
P525: LONG-TERM OUTCOMES OF STEM CELL TRANSPLANT IN OLDER P..:
Pratz, Keith
;
Dinardo, Courtney
;
L Arellano, Martha
...
HemaSphere. 7 (2023) S3 - p. e68978fe , 2023
Link:
https://doi.org/10.1097/..
?
4
Clinical and molecular response of acute myeloid leukemia h..:
Roloff, Gregory W.
;
Wen, Frank
;
Ramsland, Aubrianna
...
Haematologica. 108 (2023) 8 - p. 2234-2239 , 2023
Link:
https://doi.org/10.3324/..
?
5
Socioeconomic determinants of the biology and outcomes of a..:
Johnston, Hannah
;
Youshanlouei, Hamed Rahmani
;
Osei, Clinton
...
Blood Advances. 8 (2023) 1 - p. 164-171 , 2023
Link:
https://doi.org/10.1182/..
?
6
Impact of FLT3 Mutation on Outcomes after Venetoclax and Az..:
Konopleva, Marina
;
Thirman, Michael J.
;
Pratz, Keith W.
...
Clinical Cancer Research. 28 (2022) 13 - p. 2744-2752 , 2022
Link:
https://doi.org/10.1158/..
?
7
Efficacy and tolerability of a modified pediatric‐inspired ..:
Patel, Anand Ashwin
;
Heng, Joseph
;
Dworkin, Emily
...
eJHaem. 2 (2021) 3 - p. 413-420 , 2021
Link:
https://doi.org/10.1002/..
?
8
Venetoclax with azacitidine or decitabine in patients with ..:
Pollyea, Daniel A.
;
Pratz, Keith
;
Letai, Anthony
...
American Journal of Hematology. 96 (2020) 2 - p. 208-217 , 2020
Link:
https://doi.org/10.1002/..
?
9
MPN-288: Molecular Characteristics of IDH2-Mutated, Philade..:
Patel, Anand
;
Cahill, Kirk
;
Charnot-Katsikas, Angella
...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S335-S336 , 2020
Link:
https://doi.org/10.1016/..
?
10
Clinical outcomes of IDH2‐mutated advanced‐phase Ph‐negativ..:
Patel, Anand A.
;
Cahill, Kirk
;
Charnot‐Katsikas, Angella
...
British Journal of Haematology. 190 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1111/..
?
11
A phase 1 study of azacitidine with high-dose cytarabine an..:
Odenike, Olatoyosi
;
Stock, Wendy
;
Larson, Richard A.
...
Blood Advances. 4 (2020) 4 - p. 599-606 , 2020
Link:
https://doi.org/10.1182/..
?
12
AML-063: A Randomized, Double-Blind, Placebo-Controlled Stu..:
DiNardo, Courtney D.
;
Jonas, Brian A.
;
Pullarkat, Vinod
...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S179 , 2020
Link:
https://doi.org/10.1016/..
?
13
Entospletinib monotherapy in patients with relapsed or refr..:
Awan, Farrukh T.
;
Thirman, Michael J.
;
Patel-Donnelly, Dipti
...
Leukemia & Lymphoma. 60 (2019) 8 - p. 1972-1977 , 2019
Link:
https://doi.org/10.1080/..
?
14
Lenalidomide consolidation benefits patients with CLL recei..:
Byrd, John C.
;
Ruppert, Amy S.
;
Heerema, Nyla A.
...
Blood Advances. 2 (2018) 14 - p. 1705-1718 , 2018
Link:
https://doi.org/10.1182/..
?
15
A phase I study of selinexor in combination with high-dose ..:
Wang, Amy Y.
;
Weiner, Howard
;
Green, Margaret
...
Journal of Hematology & Oncology. 11 (2018) 1 - p. , 2018
Link:
https://doi.org/10.1186/..
1-15